Category: Approval/Launch Region: North America · United States Company: Array Biopharma Inc

ONO Submits Supplemental Applications for Approval of BRAFTOVI

By, Admin 1 min read
Share
ONO Submits Supplemental Applications for Approval of BRAFTOVI
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara;

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!